EUVIMEDEUVIMED entdecken
Open Access

Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer

Priya S Hibshman iD, Clint A Stalnecker iD, Jeffrey A Klomp iD, Kristina Drizyte-Miller iD, Jennifer E Klomp iD, A Cole Edwards iD, Lily M Pita, Richard G Hodge iD, J Nathaniel Diehl iD, Ryan D Mouery, Brandon L Mouery iD, Kayla R Snare iD und 12 weitere

Science Signaling · 2025

DOI: 10.1126/scisignal.adu7145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Priya S Hibshman und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Pancreatic Neoplasms, Proto-Oncogene Proteins p21(ras), Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Of the thousands of genes and substrates identified in KRAS-mutant signaling networks in pancreatic ductal adenocarcinoma (PDAC), more than 200 are transcription factors, implying extensive and complex transcriptional regulation. However, we observed that genetic suppression of the transcription factor MYC alone was sufficient to phenocopy the effect of KRAS suppression in signaling, growth, and metabolic processes in PDAC cells. We determined the gene transcription changes caused by acute suppression of MYC function in KRAS -mutant PDAC cell lines and performed dependency map and pathway analyses on the affected gene sets. The expression of 1685 genes was increased upon suppression of MYC, and this gene set may comprise the bulk of the MYC-regulated genes essential for PDAC growth. In contrast, the 1325 genes whose expression was inhibited may comprise a compensatory response to oncogenic stress, mediated in part by the GTPase RHO. MYC-dependent transcriptional activity was largely ERK dependent, and almost one-third of ERK-regulated genes were also regulated by MYC in PDAC cells. Furthermore, chemical proteomic profiling revealed MYC-regulated protein kinases that can be targeted therapeutically. Together, these data provide a molecular portrait of MYC-dependent signaling that encompasses potentially exploitable mechanisms for treating PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycPancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Gene Expression Regulation, NeoplasticTranscriptomeCarcinoma, Pancreatic DuctalExtracellular Signal-Regulated MAP KinasesMAP Kinase Signaling SystemHumansCell Line, TumorCell Proliferation

Substanzen

Proto-Oncogene Proteins c-mycProto-Oncogene Proteins p21(ras)KRAS protein, humanMYC protein, humanExtracellular Signal-Regulated MAP Kinases

Autor:innen und Institutionen

  • Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Illumina Inc., San Diego, CA 92122, USA.
  • Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

ORCID-Profile: Priya S Hibshman, Clint A Stalnecker, Jeffrey A Klomp, Kristina Drizyte-Miller, Jennifer E Klomp, A Cole Edwards, Richard G Hodge, J Nathaniel Diehl, Brandon L Mouery, Kayla R Snare, Andrew M Waters, Natalie K Barker, Laura A Herring, Lee M Graves, Emanuel F Petricoin, Kirsten L Bryant, Adrienne D Cox, Channing J Der

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Hibshman, P. S., Stalnecker, C. A., Klomp, J. A., Drizyte-Miller, K., Klomp, J. E., Edwards, A. C., Pita, L. M., Hodge, R. G., Diehl, J. N., Mouery, R. D., Mouery, B. L., Snare, K. R., Waters, A. M., Peng, S., Barker, N. K., Pierobon, M., Rashid, N. U., Tran, N. L., Herring, L. A., …, & Der, C. J. (2025). Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer. Science Signaling. https://doi.org/10.1126/scisignal.adu7145

Vancouver

Hibshman PS, Stalnecker CA, Klomp JA, Drizyte-Miller K, Klomp JE, Edwards AC, et al. Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer. Science Signaling. 2025. doi:10.1126/scisignal.adu7145

BibTeX
@article{Hibshman2025,
  author = {Hibshman, Priya S and Stalnecker, Clint A and Klomp, Jeffrey A and Drizyte-Miller, Kristina and Klomp, Jennifer E and Edwards, A Cole and Pita, Lily M and Hodge, Richard G and Diehl, J Nathaniel and Mouery, Ryan D and Mouery, Brandon L and Snare, Kayla R and Waters, Andrew M and Peng, Sen and Barker, Natalie K and Pierobon, Mariaelena and Rashid, Naim U and Tran, Nhan L and Herring, Laura A and Graves, Lee M and Petricoin, Emanuel F and Bryant, Kirsten L and Cox, Adrienne D and Der, Channing J},
  title = {Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer},
  journal = {Science Signaling},
  year = {2025},
  doi = {10.1126/scisignal.adu7145}
}
Kostenlos starten →